TotalMarketCap

Lantern Pharma

LTRNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$8.092 M

$0.54 -7.64%

Close of 6 Nov 2026

As of 6 Nov 2026, Lantern Pharma (LTRN) has a market capitalization of $8.09M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$17.1M

Loss-making

Shares outstanding

12,784,146

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #424Lexaria BioscienceLEXX$8.78M
  2. #425CalciMedicaCALC$8.71M
  3. #426Lantern PharmaLTRN$8.09M
  4. #427Alaunos TherapeuticsTCRT$7.51M
  5. #428Tempest TherapeuticsTPST$7.51M

What if Lantern Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,890,578

Per share 3,489,439× higher

Bitcoin $1.53T

$102,295.89

Per share 188,807× higher

Apple $5.02T

$335,827.87

Per share 619,837× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Lantern Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.